Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial. [PDF]
Cho BC +38 more
europepmc +1 more source
Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancer. [PDF]
Hanna J +10 more
europepmc +1 more source
Complexation of the Antineoplastic Docetaxel with γ‑Cyclodextrin Significantly Improves Its Solubility and <i>In Vitro</i> Safety. [PDF]
Sampaio TS +9 more
europepmc +1 more source
Cost-effectiveness analysis of neoadjuvant docetaxel plus androgen deprivation therapy before radical prostatectomy in high-risk localized prostate cancer. [PDF]
Liu Q +6 more
europepmc +1 more source
Uncertain magnitude of benefit of early second-generation androgen receptor antagonist treatment in advanced prostate cancer. [PDF]
van de Weerdt EK +3 more
europepmc +1 more source
Fatal Interstitial Pneumonitis During Combined Degarelix, Darolutamide, and Docetaxel Therapy for Metastatic Prostate Cancer. [PDF]
Ito F +4 more
europepmc +1 more source
Patient-derived cell lines unveil COL1A2 as a predictor of docetaxel resistance in breast cancer. [PDF]
Gao Y +8 more
europepmc +1 more source
Enhanced Antitumor Effects by Docetaxel/LL37-Loaded Thermosensitive Hydrogel Nanoparticles in Peritoneal Carcinomatosis of Colorectal Cancer [Retraction]. [PDF]
europepmc +1 more source

